<DOC>
	<DOCNO>NCT02548585</DOCNO>
	<brief_summary>A Phase 1/2 , multiple dose study 6 cohort ascend dos design evaluate efficacy , safety pharmacokinetics ( PK ) MEDI0382 patient Type 2 Diabetes Mellitus ( T2DM ) .</brief_summary>
	<brief_title>A Multiple-ascending-dose Study Evaluate Efficacy , Safety , Pharmacokinetics ( PK ) MEDI0382 Overweight Obese Subjects With Type 2 Diabetes</brief_title>
	<detailed_description>This randomize , double-blind , placebo control study design evaluate efficacy , safety , PK MEDI0382 administer multiple daily SC dose subject T2DM . Approximately one hundred seven subject enrol across 6 cohort . In cohort 1-3 subject randomize MEDI0382 placebo ( 3:1 ) . In Cohort 4 , subject randomize 1:1 . In cohort 5 6 subject randomize MEDI0382 placebo ( 3:1 ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Diagnosis T2DM , age 1865 Must provide write informed consent BMI &gt; 27 &lt; 40 kg/m2 , inclusive Venous access suitable multiple cannulation Vital sign within normal specified range Females must nonlactating nonchildbearing potential Males must practice 2 effective contraceptive measure sexually active Any concurrent condition opinion investigator would interfere evaluation investigational product History presence gastrointestinal , renal , hepatic disease condition know interfere absorption , distribution , metabolism , excretion drug History cancer within last 10 year , exception nonmelanoma skin cancer Any clinically important illness ( except T2DM ) , medical/surgical procedure , trauma within 4 week prior dose Fasting glucose â‰¥ 200 mg/dL Positive Hepatitis B , Hepatitis C HIV test use antiretroviral medication screen . Concurrent previous use GLP1 receptor agonist Current previous use systemic corticosteroid within past 28 day prior screen Use medicinal product herbal preparation license control body weight appetite prohibit . Known suspected history alcohol drug abuse within past 3 year . Positive drug screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>MEDI0382 , diabetes</keyword>
</DOC>